GOSH Consultant, Dr Emma Clement, joins the North Thames Genomic Medicine Service as Deputy Medical Director

12 Jan 2026, 10:56 a.m.

A woman with short brown hair is smiling.

We are delighted to share that Dr Emma Clement has joined the North Thames Genomic Medicine Service (NT GMS) Deputy Medical Director. She joins the NT GMS senior team and will work alongside Medical Director, Dr Angela George, and COO, Anthony Sullivan, to deliver the genomics ambitions of the 10-Year Plan.

Dr Sophia Varadkar, GOSH Acting Chief Medical Officer and Acting Senior Responsible Officer for the NT GMS said: “We are absolutely delighted to welcome Dr Emma Clement as Deputy Medical Director for the North Thames Genomic Medicine Service, she brings with her fantastic experience of integrating genomics into routine clinical care which will be vital as the service continues to expand.”

Dr Clement has been a Consultant in Clinical Genetics and Genomic Medicine at GOSH since 2017 and played a significant role in the delivery of the 100,000 genomes project at the hospital. She has a specialist interest in paediatric rare disease, particularly in the genetics of hearing loss and dual sensory conditions.

Dr Angela George, NT GMS Medical Director said: "It is fantastic to have Dr Emma Clement joining our NT GMS team and I am excited to be working with her as we continue to build our service. Emma’s track record in embedding genomics into routine clinical care, alongside her leadership in education and paediatric rare disease, will be invaluable as we deliver our ambitions across North Thames and improve outcomes for patients."

Dr Clement brings a wealth of experience to the role, having worked closely with other clinical teams across GOSH to embed genomic sequencing into routine care.

Dr Emma Clement said: "I am really happy to be stepping into the role of Deputy Medical Director for the North Thames GMS. I'm looking forward to working collaboratively across our region to help embed genomics into routine patient care."

NHS eye gene therapy restores Saffie's sight

Saffie has had her sight restored thanks to life-changing eye gene therapy for rare blindness at GOSH

£3M study led by patient voices targets pain in inflammatory arthritis

A new £3 million research programme involving Great Ormond Street Hospital and University College London researchers aims to tackle one of the largest unmet clinical needs in inflammatory arthritis – pain reduction.

Transport for London (TfL) strikes: April and May 2026

There are upcoming London Underground strikes planned which may affect your journey to GOSH.

Liquids to solids: the simple trick transforming children's lives and saving thousands of pounds

Switching children and young people’s medication from liquids to pills can transform their lives and save thousands of pounds for the NHS at the same time.